PALI RSI Chart
Last 7 days
29.3%
Last 30 days
1.5%
Last 90 days
-21.9%
Trailing 12 Months
-77.7%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 108.1K | 155.4K | 202.7K | 250.0K |
2022 | 0 | 0 | 0 | 60.8K |
2020 | 18.9K | 13.5K | 13.5K | 13.5K |
2019 | 198.8K | 137.7K | 76.5K | 15.4K |
2018 | 260.0K | 260.0K | 260.0K | 260.0K |
2017 | 16.2K | 16.2K | 16.2K | 260.0K |
2016 | 10.0K | 10.0K | 10.0K | 16.2K |
2015 | 17.6K | 15.1K | 12.6K | 10.4K |
2014 | 11.7K | 14.2K | 16.7K | 18.8K |
2013 | 354.0K | 278.3K | 110.0K | 110.0K |
2012 | 394.9K | 399.2K | 403.4K | 407.7K |
2011 | 0 | 0 | 562.0K | 390.6K |
2010 | 0 | 0 | 0 | 733.4K |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Mar 11, 2024 | finley john david | acquired | - | - | 5,558 | ceo, cfo, director |
Feb 09, 2024 | neal james r | acquired | - | - | 10,920 | - |
Feb 08, 2024 | trenschel robert j. | acquired | - | - | 10,920 | - |
Feb 08, 2024 | csimma cristina | acquired | - | - | 12,800 | - |
Feb 08, 2024 | diaz stephanie | acquired | - | - | 12,800 | - |
Feb 06, 2024 | jones mitchell lawrence | sold (taxes) | -938 | 0.4361 | -2,153 | chief medical officer |
Feb 06, 2024 | jones mitchell lawrence | acquired | - | - | 6,891 | chief medical officer |
Feb 06, 2024 | finley john david | acquired | - | - | 6,642 | ceo, cfo, director |
Feb 06, 2024 | finley john david | bought | 4,692 | 0.4692 | 10,000 | ceo, cfo, director |
Jan 31, 2024 | finley john david | bought | 5,590 | 0.559 | 10,000 | ceo, cfo, director |
Which funds bought or sold PALI recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
Apr 23, 2024 | BFSG, LLC | new | - | 16.00 | 16.00 | -% |
Mar 11, 2024 | VANGUARD GROUP INC | unchanged | - | 545 | 40,152 | -% |
Feb 26, 2024 | Virtu Financial LLC | new | - | 31,000 | 31,000 | -% |
Feb 14, 2024 | STATE STREET CORP | unchanged | - | 180 | 13,253 | -% |
Feb 14, 2024 | TWO SIGMA SECURITIES, LLC | new | - | 11,595 | 11,595 | -% |
Feb 13, 2024 | GEODE CAPITAL MANAGEMENT, LLC | unchanged | - | 276 | 20,324 | -% |
Feb 13, 2024 | MORGAN STANLEY | added | 3.33 | 57.00 | 1,244 | -% |
Feb 13, 2024 | FMR LLC | new | - | 22.00 | 22.00 | -% |
Feb 13, 2024 | BlackRock Inc. | unchanged | - | - | 5.00 | -% |
Feb 13, 2024 | NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | unchanged | - | - | 1.00 | -% |
Unveiling Palisade Bio, Inc.'s Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Palisade Bio, Inc.)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 41.2B | 6.8B | -8.75 | 6.02 | ||||
HILS | 22.4B | 152.6K | -2.4K | 146.8K | ||||
ALNY | 18.0B | 1.8B | -41 | 9.87 | ||||
BMRN | 15.4B | 2.5B | 74.73 | 6.21 | ||||
INCY | 11.6B | 3.7B | 19.41 | 3.14 | ||||
MID-CAP | ||||||||
APLS | 6.0B | 396.6M | -11.37 | 15.16 | ||||
BBIO | 4.4B | - | -6.7 | 60.35 | ||||
AXSM | 3.4B | 270.6M | -14.22 | 12.57 | ||||
ACAD | 2.8B | 726.4M | -44.9 | 3.79 | ||||
ARWR | 2.7B | 240.7M | -9.23 | 12.18 | ||||
SMALL-CAP | ||||||||
CPRX | 1.8B | 398.2M | 24.58 | 4.41 | ||||
NVAX | 569.6M | 983.7M | -1.05 | 0.58 | ||||
CRBP | 361.2M | 881.7K | -8.1 | 466.16 | ||||
INO | 247.0M | 4.9M | -1.83 | 50.76 | ||||
IBIO | 6.1M | 2.1M | -0.22 | 2.14 |
Palisade Bio, Inc. News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 | 2018Q1 | 2017Q4 | 2017Q3 | 2017Q2 | 2017Q1 |
Revenue | - | - | - | - | 250 | 126 | 3.00 | 3.00 | 3.00 | 6.00 | 3.00 | 3.00 | 8.00 | 5.00 | 3.00 | 3.00 | 253 | 253 | 253 | 3.00 | 3.00 | 3.00 |
Operating Expenses | -16.5% | 3,154 | 3,778 | 3,609 | 2,779 | 3,848 | 3,444 | 1,816 | 1,841 | 1,996 | 2,135 | 2,127 | 1,926 | 2,459 | 1,807 | 2,085 | 2,275 | 2,351 | - | - | - | - |
S&GA Expenses | -6.9% | 1,558 | 1,674 | 1,432 | 1,538 | 1,505 | 2,382 | 1,404 | 1,191 | 1,300 | 1,368 | 1,301 | 972 | 945 | 928 | 1,188 | 1,261 | 1,182 | - | - | - | - |
R&D Expenses | - | - | - | - | - | - | 410 | 466 | 446 | 697 | 767 | 825 | 954 | 1,514 | 879 | 897 | 1,015 | 1,169 | 1,225 | 1,384 | 2,585 | 2,902 |
Interest Expenses | -50.0% | 4.00 | 8.00 | 3.00 | - | 3.00 | - | 28.00 | 11.00 | 3.00 | 4.00 | 2.00 | 507* | 2.00 | 4.00 | 1.00 | 772* | - | - | - | - | - |
Net Income | 17.4% | -2,971 | -3,596 | -3,393 | -2,340 | -3,720 | -4,244 | -1,843 | -1,851 | -2,384 | -2,037 | -1,763 | -1,436 | -3,113 | -320 | -1,830 | -627 | -2,146 | - | - | - | - |
Net Income Margin | 23.6% | -49.20* | -64.37* | -86.51* | -114.65* | -234.48* | -763.46* | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Free Cashflow | -3.2% | -2,746 | -2,662 | -2,209 | -3,536 | -3,316 | -1,549 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Assets | -17.7% | 14,052 | 17,067 | 18,290 | 15,262 | 15,763 | 16,266 | 7,806 | 8,350 | 12,512 | 16,274 | 14,949 | 8,915 | 3,019 | 15,170 | 17,102 | 11,361 | 6,584 | 8,944 | 3,522 | 5,406 | 7,684 |
Current Assets | -18.1% | 13,328 | 16,266 | 17,411 | 14,309 | 14,733 | 15,158 | 7,415 | 8,258 | 11,506 | 16,092 | 14,725 | 8,756 | 896 | 14,991 | 16,242 | 10,464 | 5,647 | 7,966 | 2,708 | 4,538 | 6,508 |
Cash Equivalents | -18.8% | 12,432 | 15,312 | 16,403 | 13,297 | 12,383 | 13,985 | 4,980 | 6,644 | 10,495 | 14,104 | 12,653 | 615 | 713 | 751 | 1,519 | 10,030 | 5,115 | 7,300 | 2,281 | 4,005 | 5,787 |
Net PPE | 0% | 10.00 | 10.00 | 11.00 | 9.00 | 10.00 | 12.00 | 2.00 | 2.00 | 3.00 | 3.00 | 3.00 | 7.00 | 5.00 | 15.00 | 22.00 | 31.00 | 41.00 | 52.00 | 63.00 | 76.00 | 90.00 |
Liabilities | -8.2% | 2,739 | 2,985 | 2,490 | 1,515 | 3,284 | 3,836 | 3,595 | 3,558 | 5,147 | 12,354 | 24,393 | 1,186 | 10,118 | 1,047 | 867 | 1,383 | 1,458 | 1,901 | 1,559 | 2,134 | 1,635 |
Current Liabilities | -2.4% | 2,586 | 2,649 | 2,335 | 1,315 | 3,012 | 3,513 | 2,860 | 1,864 | 2,496 | 2,920 | 3,850 | 1,015 | 8,082 | 1,002 | 676 | 1,186 | 1,225 | 1,581 | 1,071 | 1,210 | 1,051 |
Long Term Debt | - | - | - | - | - | - | - | - | - | - | - | - | - | 94.00 | - | - | - | - | - | - | - | - |
LT Debt, Non Current | - | - | - | - | - | - | - | - | - | - | - | - | - | 94.00 | - | - | - | - | - | - | - | - |
Shareholder's Equity | -19.7% | 11,313 | 14,082 | 15,800 | 13,747 | 12,479 | 12,430 | 4,211 | 4,792 | 7,365 | 3,920 | - | 7,729 | 9,768 | 14,122 | 16,234 | 9,978 | 5,126 | 7,043 | 1,963 | 3,272 | 6,050 |
Retained Earnings | - | 121,500 | - | - | - | - | - | - | - | - | -95,715 | -103,800 | -240,527 | -68,026 | -233,823 | -231,501 | -229,550 | -221,975 | -219,937 | -218,174 | -216,737 | -213,623 |
Additional Paid-In Capital | 0.2% | 132,724 | 132,523 | 130,652 | 125,229 | 121,637 | 116,839 | 105,180 | 103,454 | 102,002 | 99,503 | 94,242 | 248,228 | 51,396 | 247,775 | 247,568 | 239,440 | 227,067 | 226,958 | 220,125 | 219,993 | 219,655 |
Shares Outstanding | 0.7% | 618 | 614 | 457 | 304 | 196 | 38.00 | 24.00 | 22.00 | 19.00 | 11.00 | 15.00 | 4.00 | - | - | - | - | - | - | - | - | - |
Float | - | - | - | 11,600 | - | - | - | 8,100 | - | - | - | 39,200 | - | - | - | 12,444 | - | - | - | 4,578 | - | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Cashflow From Operations | -3.2% | -2,746 | -2,662 | -2,199 | -3,526 | -3,306 | -3,040 | -3,250 | -3,764 | -3,055 | -2,746 | -7,722 | -1,250 | -1,548 | -869 | -673 | -1,677 | -2,048 | -1,897 | -1,643 | -1,665 | -1,658 |
Share Based Compensation | -8.4% | 185 | 202 | 144 | 93.00 | 86.00 | 252 | 336 | 358 | 683 | 144 | 495 | 569 | 470 | 664 | 804 | 76.00 | 119 | 295 | 129 | 338 | 64.00 |
Cashflow From Investing | - | - | - | - | - | -10.00 | - | - | - | - | -348 | - | - | -1.00 | 1.00 | - | - | - | - | - | - | -1.71 |
Cashflow From Financing | -108.5% | -134 | 1,571 | 5,309 | 4,440 | 1,714 | 12,045 | 1,586 | -87.00 | -554 | 4,545 | 19,466 | 1,152 | 1,511 | 100 | -6,314 | 6,593 | -136 | 6,922 | -78.85 | -117 | 1,712 |
Consolidated Statements of Operations - USD ($) $ in Thousands | 12 Months Ended | |
---|---|---|
Dec. 31, 2023 | Dec. 31, 2022 | |
Operating expenses: | ||
License revenue | $ 250 | $ 0 |
Research and development | 6,893 | 6,547 |
General and administrative | 6,202 | 8,764 |
Restructuring costs (Note 9) | 225 | 410 |
Total operating expenses | 13,320 | 15,721 |
Loss from operations | (13,070) | (15,721) |
Other income (expense): | ||
Interest expense | (15) | (13) |
Other income | 785 | 2,584 |
Loss on issuance of warrants | 0 | (1,110) |
Total other income, net | 770 | 1,461 |
Net loss | (12,300) | (14,260) |
Net loss available to common stockholders | $ (12,316) | $ (14,548) |
Loss per common share: | ||
Basic net loss per common share | $ (1.8) | $ (16.53) |
Diluted net loss per common share | $ (1.8) | $ (16.53) |
Weighted average shares used in computing loss per common share: | ||
Basic weighted average shares used in computing net loss per common share | 6,840,213 | 880,311 |
Diluted weighted average shares used in computing net loss per common share | 6,840,213 | 880,311 |
Consolidated Balance Sheets - USD ($) | Dec. 31, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 12,432,000 | $ 12,383,000 |
Prepaid expenses and other current assets | 896,000 | 2,350,000 |
Total current assets | 13,328,000 | 14,733,000 |
Restricted cash | 26,000 | 26,000 |
Property and equipment, net | 10,000 | 10,000 |
Operating lease right-of-use asset | 198,000 | 300,000 |
Other noncurrent assets | 490,000 | 694,000 |
Total assets | 14,052,000 | 15,763,000 |
Current liabilities: | ||
Accounts payable | 698,000 | 1,759,000 |
Accrued liabilities | 831,000 | 574,000 |
Accrued compensation and benefits | 778,000 | 486,000 |
Current portion of operating lease liability | 121,000 | 105,000 |
Insurance financing debt | 158,000 | 88,000 |
Total current liabilities | 2,586,000 | 3,012,000 |
Warrant liability | 2,000 | 61,000 |
Contingent consideration obligation | 61,000 | 0 |
Lease liability, net of current portion | 90,000 | 211,000 |
Total liabilities | 2,739,000 | 3,284,000 |
Commitments and contingencies (Note 9) | ||
Stockholders' equity: | ||
Common stock, $0.01 par value; 280,000,000 shares authorized; 9,270,894 and 2,944,306 shares issued and outstanding at December 31,2023 and December 31, 2022, respectively | 93,000 | 30,000 |
Additional paid-in capital | 132,724,000 | 121,637,000 |
Accumulated deficit | (121,506,000) | (109,190,000) |
Total stockholders' equity | 11,313,000 | 12,479,000 |
Total liabilities and stockholders' equity | 14,052,000 | 15,763,000 |
Series A Preferred Stock [Member] | ||
Stockholders' equity: | ||
Series A Convertible Preferred Stock, $0.01 par value, 7,000,000 shares authorized; 200,000 issued and outstanding at December 31, 2023 and December 31, 2022 | $ 2,000 | $ 2,000 |